Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of ...

MONTREAL, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today

Related Keywords

Canada ,Montreal ,Quebec ,Philippe Dubuc ,Julie Schneiderman ,Sudocetaxel Zendusortide ,Communications Corporate Affairs ,Theratechnologies Inc ,Company Phase ,Forward Looking Statements ,Looking Statements ,Annual Information Form ,Vice President ,Chief Financial ,Region ,